Axsome Therapeutics, Inc. (AXSM) Balance sheet

Market cap

$12.1B

P/E ratio

	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	-	-	-	-	184	86	201	386	315	323
Total cash & short-term investments	-	-	-	-	184	86	201	386	315	323
Accounts receivable, net	-	-	-	-	-	-	38	95	142	224
Inventories	-	-	-	-	-	-	4	15	16	28
Total current assets	38	35	15	220	184	87	246	504	485	589
Property, plant and equipment, net	100,730	68,071	51,832	30,623	52,647	283,846	722,515	1	1	1
Total assets	38	36	15	221	186	88	331	588	568	690
Accounts payable	4	3	4	11	14	13	39	41	72	66
Long-term debt, current	269,162	3	3	3	-	-	-	-	-	70
Total current liabilities	7	12	11	24	23	23	97	139	230	379
Long-term debt, non-current	9	7	4	17	48	49	94	178	181	118
Total liabilities	17	19	14	42	72	72	222	397	511	602
Retained earnings	-47,641,451	-76,584,843	-107,550,307	-175,895,493	-279	-409	-596	-836	-1,123	-1,306
Stockholders' equity	22	17	937,921	179	114	16	110	191	57	88
Working capital	-	-	-	-	-	-